| Page 56 | Cafepharma

You are here

Primary tabs

Innovation Pharmaceuticals Reports on Successful Phase II Trial of Brilacidin-OM for Oral Mucositis

Post date: April 9, 2018 - 3:14pm

The Great Drive to Develop Treatments for NASH continues with Second Genome Presenting Data Supporting Development of Its P2X7 Inhibitor, SGM-1019

Post date: April 9, 2018 - 3:12pm

Preliminary positive results for Phase I - II trial of Tesaro's Zejula with Keytruda in platinum-resistant ovarian cancer

Post date: March 26, 2018 - 2:38pm

Allergan - Forest gender discrimination $4 million settlement final date approaching

Post date: March 22, 2018 - 3:44pm

Top 5 boards for week ending March 10, 2018

Post date: March 11, 2018 - 3:01pm

Top 5 viewed boards for week ending March 3, 2018

Post date: March 4, 2018 - 1:48pm

Release: Skyline Medical and Helomics Announce a Joint Strategic Partnership with GLG Pharma in the Ovarian and Breast Cancer Spaces

Post date: March 2, 2018 - 9:40am

Release: BASF launches Hepaxa as first dedicated product in the U.S. to help patients manage Non-Alcoholic Fatty Liver Disease

Post date: February 23, 2018 - 12:26am

Recent Job Ratings on Cafepharma - Stryker, Kowa, IQVIA ($SYK, $IQV)

Post date: February 21, 2018 - 10:37pm

Last week in pharma.bio.device.lab November 5-11 2017

Post date: November 12, 2017 - 2:16pm

Pages